The apoptotic deletion of thymocytes that express self-reactive antigen rec
eptors is the basis: of central (thymic) self-tolerance. However, it is cle
ar that some autoreactive T cells escape deletion in the thymus and exist a
s mature lymphocytes in the periphery. Therefore, peripheral mechanisms of
tolerance are also crucial, and failure of these peripheral mechanisms lead
s to autoimmunity. Clonal deletion, clonal anergy and immunoregulation and/
or suppression have been suggested as mechanisms by which 'inappropriate' T
-lymphocyte responses may be controlled in the periphery. Peripheral clonal
deletion, which improves the apoptotic elimination of lymphocytes, is crit
ical for T-cell homeostasis during normal immune responses, and is recogniz
ed as an important process by which self-tolerance is maintained. Transplan
tation of foreign tissue into an adult host represents a special case of 'i
nappropriate' T-cell reactivity that is subject to the same central and per
ipheral tolerance mechanisms that control reactivity against self. In this
case, the unusually high frequency of naive T cells able to recognize and r
espond against non-self-allogeneic major historumpatility complex (MHC) ant
igens leads to an exceptionally large pool of pathogenic effector lymphocyt
es that must be controlled if graft rejection is to be avoided. A great dea
l of effort has been directed towards understanding the role of clonal aner
gy and/or active immunoregulation in the induction of peripheral transplant
ation tolerance but, until recently; relatively little progress had been ma
de towards defining the potential contribution of clonal deletion. Here, we
outline recent data that define a clear requirement for deletion in the in
duction of peripheral transplantation tolerance across MHC barriers, and di
scuss the potential implications of these results in the context of current
treatment modalities used in the clinical transplantation setting.